Patient willingness to de-escalate adjuvant therapy based on predictive biomarker results in stage IIB-IIID melanoma: A cross-sectional survey
European Journal of Cancer · 2026-11 · 248 · 117061
DOI: 10.1016/j.ejca.2026.117061 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift European Journal of Cancer, 2026-11. Verfasst von Chiara L Blomen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venerology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany; Fleur Hiege Center for Skin Cancer Research,…. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Melanoma, Patient Preference, Skin Neoplasms. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Cancer Aid.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology and Venerology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany; Fleur Hiege Center for Skin Cancer Research, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany; Mildre…
- Department of Dermatology and Venerology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
- Department of Dermatology and Venerology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany; Fleur Hiege Center for Skin Cancer Research, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
- Department of Medical Psychology, Centre for Psychosocial Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
Förderung
- German Cancer Aid
Zitieren
APA
Blomen, C. L., Kelpe, J., Kött, J., Rutenkröger, M., Scholl, I., Schneider, S. W., & Gebhardt, C. (2026). Patient willingness to de-escalate adjuvant therapy based on predictive biomarker results in stage IIB-IIID melanoma: A cross-sectional survey. European Journal of Cancer, 248, 117061. https://doi.org/10.1016/j.ejca.2026.117061
Vancouver
Blomen CL, Kelpe J, Kött J, Rutenkröger M, Scholl I, Schneider SW, et al. Patient willingness to de-escalate adjuvant therapy based on predictive biomarker results in stage IIB-IIID melanoma: A cross-sectional survey. European Journal of Cancer. 2026;248:117061. doi:10.1016/j.ejca.2026.117061
BibTeX
@article{Blomen2026,
author = {Blomen, Chiara L and Kelpe, Jana and Kött, Julian and Rutenkröger, Mareike and Scholl, Isabelle and Schneider, Stefan W and Gebhardt, Christoffer},
title = {Patient willingness to de-escalate adjuvant therapy based on predictive biomarker results in stage IIB-IIID melanoma: A cross-sectional survey},
journal = {European Journal of Cancer},
year = {2026},
volume = {248},
pages = {117061},
doi = {10.1016/j.ejca.2026.117061}
}
EUVIMED